Series date: 
01/01/2024 - 7:00pm to 12/31/2024 - 8:00pm
COURSE DIRECTOR
David J. Daniels, M.D., Ph.D.

DESCRIPTION:
The Enterprise Morbidity and Mortality will be a quarterly course that's main outcome is to improve Patient Outcome: This will be a tri-site meeting based out of Rochester. Each site will be going over mortality and morbidity patient cases. Discussing difficult cases and ways they can improve future patient outcomes, for educational purposes. 

TARGET AUDIENCE:
NPs and PAs in Radiation Oncology, no prerequisite skills

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:
  • Review the potential long-term neuro-degenerative consequences of a concussion and the potential of a serious brain injury.
  • Identify unusual presentations and natural history of neurosurgical related trauma.

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


 

Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with ineligible companies:
None

All relevant financial relationships have been mitigated. 

No relevant financial relationship(s) with ineligible companies:
David Daniels, M.D., Ph.D;
Maria Peris Celda, M.D. Ph.D;
Alicia McCain
Daks Marquart (Coordinator)
Mary Meyer (Coordinator)

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

QUESTIONS?
Contact:  Mary Meyer or Daks Marquart

Support location: 
Minnesota

Sessions

Session Date
Quarterly Enterprise Morbidity and Mortality : January 17, 2024 01/17/2024 - 7:00pm to 8:00pm
CANCELLED Quarterly Enterprise Morbidity and Mortality April 24 2024 04/24/2024 - 7:00pm to 8:00pm
Quarterly Enterprise Morbidity and Mortality May 15 2024 05/15/2024 - 7:00pm to 8:00pm